Sugar Scout is a cutting-edge biotech initiative dedicated to advancing at-home diagnostic solutions for gut health. Our flagship product focuses on the detection and management of fructose malabsorption, a common yet often overlooked digestive condition. By leveraging innovative enzyme technology, we have developed a urine-based diagnostic test that provides accurate, reliable, and non-invasive results.
Our approach combines state-of-the-art fructose oxidase and lactate dehydrogenase enzymes in a streamlined lateral flow assay format, ensuring that users can gain critical insights into their digestive health quickly and conveniently. Designed with accessibility in mind, Sugar Scout empowers individuals to take control of their well-being by enabling early detection and personalized management of gut health issues.
At Sugar Scout, we are committed to creating impactful solutions that bridge the gap between complex medical diagnostics and everyday healthcare. By promoting awareness of gut health and providing practical tools for its monitoring, we aim to foster healthier lifestyles and improve quality of life for people worldwide.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Boston, Massachussetts, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Dharuhera.
- HQ
- Boston, Massachussetts
Sugarscout Questions
Sugarscout's LinkedIn profile is https://www.linkedin.com/company/sugarscout28
Sugarscout has
3 employees.
View email and phone details for 3
employees at Sugarscout.
Sugarscout's industry is
Biotechnology Research
Sugarscout's top competitors are
Black Mountain Investments,
Phi Gamma Nu - Boston University,
Naveen Aqua Chemicals,
Parkview Advance,
Nature Bio Science,
The Wyse Group,
H1h2 Capital,
Medtel.com,
Grey Ledge Advisors,
Berkeley Pharma Tech.
Sugarscout's categories are Biotechnology Research
Sugarscout's founding year is 2024
